Author | Hope Rugo, MD | OncLive

Author | Hope Rugo, MD

Articles

Dr. Rugo on the Optimal Setting for Biosimilar Evaluation

November 20, 2018

Video

Hope Rugo, MD, professor of medicine, director of the Breast Oncology Clinical Trials Program, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses the optimal setting for biosimilar evaluation.

Dr. Rugo on Resistance to CDK4/6 Inhibitors in HR+ Breast Cancer

November 14, 2018

Video

Hope Rugo, MD, professor of medicine, director of the Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center, discusses resistance to CDK4/6 inhibitors in hormone receptor (HR)-positive breast cancer.

Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars

November 03, 2018

Video

Hope Rugo, MD, professor of medicine, director of the Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the equivalency that has been demonstrated with biosimilars for trastuzumab (Herceptin).

Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars

October 27, 2018

Video

Hope Rugo, MD, professor of medicine, director of the Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center, discusses a comparative review of trastuzumab (Herceptin) biosimilars.

x